Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases

Summary

This phase I trial studies the side effects and best dose of ropidoxuridine when given together with whole brain radiation therapy in treating patients with cancer that has spread to the brain (brain metastases). Ropidoxuridine may help whole brain radiation therapy work better by making cancer cells more sensitive to the radiation therapy.

Timeline

Start

2017-05-08

Primary completion

2022-08-19

Completion

2026-10-03

Drugs

Indications